Central Blood Pressure Evaluation In Interventional Valve Reconstruction

Central Blood Pressure Evaluation In Interventional Valve Reconstruction - CEBPELIN – IVORY

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00011289

Enrollment

450

Registered

2017-01-19

Start date

2016-11-24

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I35 I34

Interventions

Group 1: In patients recieving a TAVI in medical routine a non-invasive, oscillometric measurement of hemodynamic parameters via brachial cuff ist performed. Measurements are done prior and after inte

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: -given informed consent -recieving TAVI, MitraClip or left heart catheterization in clinical routine

Exclusion criteria

Exclusion criteria: contraindications against simultanous blood pressure measurements on both arms (dialysis shunt, mamma-CA and others) systolic blood pressure difference >15 mmHg of both arms

Design outcomes

Primary

Measure	Time frame
This study aims at improving the understanding in short to midterm changes in hemodynamics in patients undergoing interventional valve reconstruction and replacement. These data compared to baseline parameters and clinical evaluation may lead to a better risk stratificiation regarding preiprocedural complications and outcomes.	—

Countries

Germany

Contacts

Public ContactFabian Hoffmann

Medizinische Klinik III, Herzzentrum des Universitätsklinikums Köln, Hypertoniezentrum

fabian.hoffmann@uk-koeln.de0221 478 32401

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026